Herantis Pharma Names Kyösti Kakkonen Chair of Shareholders’ Nomination Committee

PUBT · 2d ago
Herantis Pharma Names Kyösti Kakkonen Chair of Shareholders’ Nomination Committee
  • Herantis Pharma appointed Kyösti Kakkonen, representing Joensuun Kauppa ja Kone Oy, as nomination committee chair on October 28, 2026.
  • Timo Syrjälä joins the committee representing himself and Acme Investments SPF.
  • Petteri Vaarnanen was appointed to represent Säästöpankki Pienyhtiöt and Säästöpankki Kotimaa funds.
  • Board Chair Timo Veromaa serves as the fourth committee member.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Herantis Pharma Oyj published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.